This webinar will discuss the timeline for the implementation of the Drug Supply Chain Security Act (DSCSA) requirements and how regulations will be impacted. Review findings from NABP’s Drug Distributor Accreditation and OTC Medical Device Distributor Accreditation programs, including instances of counterfeit drugs and distribution inconsistencies in the supply chain.
NABP’s accreditation programs play a pivotal role in preventing counterfeit drugs and devices from entering the United States drug supply. You will gain the information needed to avoid drug shortage diversion schemes and learn how NABP accreditation and inspection programs protect the public health.
This webinar is a recording of the live session that was held on March 11, 2022.
This webinar is not eligible for Accreditation Council for Pharmacy Education-accredited continuing pharmacy education credit.
RegisterPresenter
Gregg Jones, BSPharm, RPh, Compliance Senior Manager, NABP
Gregg Jones is the Compliance Senior Manager at NABP, playing a critical role in the process of evaluating businesses for compliance with regulations and NABP accreditation program requirements. Prior to his role, Gregg gained extensive experience in various areas, including pharmacy and drug, medical devices, and cosmetic regulation. His background also includes the practice of pharmacy in both hospital and retail settings. Gregg’s background led him to a diverse expertise in accreditation and inspection at the national level. He also testified before Congress and a statewide grand jury regarding the counterfeiting and diversion of prescription drugs. Gregg graduated from Florida Southern College with a bachelor degree in biology and from the University of Louisiana Monroe with a bachelor degree in pharmacy.